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Considering  the increase  in  consumption  of  Cannabis  sativa  and  the  use  of  the  compound  ˇ-carotene
(BC)  as  supplement,  we  investigated  potential  changes  in the  chemical  and  biological  proprieties  of  BC
after  exposure  to C. sativa  smoke  (CSS).  Our  results  showed  that  the  BC exposed  to  CSS  underwent  98.8%
degradation  and  suffered  loss  of  its antiradical  activity.  The  major  degradation  products  identiﬁed  were  3-
hydroxy-2,4,4-trimethylpentyl)2-methylpropanoate  and  (2-ethyl-3-hydroxyhexyl)2-methylpropanoate
compounds.  These  are  found  in higher  levels  in the exhalations  of colorectal  cancer  patients  and  are
similar  to  the  toxic  products  associated  with  lipid  peroxidation  of  polyunsaturated  fatty  acids.  In toxico-
logical  assays  using  micro-crustacean  Artemia  salina  the BC  was  non-toxic,  while  the  BC  degraded  by  CSS
had a  toxicity  of  LC50 =  397.35  g/mL.  In Wistar  rats, females  treated  with  BC  degraded  by CSS  (BCCSS)
showed  whitish  liver  spots,  alterations  in liver weight  and in  bilirubin  and alkaline  phosphatase  levels,
and  decrease  in  the  number  of  leukocytes  associated  with  atypical  lymphocytosis.  In  male  rats,  there
was  an  increase  in the  number  of  leukocytes  when  compared  to the control  group.  In  the  histopatholog-
ical  analysis,  the  cortical  region  of  the  kidneys  showed  the  presence  of  discrete  amorphous  eosinophilic
material  (cylinders)  in  the lumen  of  the  proximate  and distal  convoluted  tubules.  In general,  the BC  in
contact  with  CSS  undergoes  chemical  changes  and  exhibits  toxicity  to rats  and  Artemia  salina.
© 2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
Carotenoids are widely studied due to their beneﬁcial biological
ctivities in health. More than 700 carotenoids have been identiﬁed
1]. Only about 50, however, are precursors of vitamin A [2]. The ˇ-
arotene (BC), besides being one of the most abundant carotenoids
n nature, is the only one that is converted into two  molecules of
itamin A. The concentration of BC in human serum is about 0.4 M
3,4].
In the past two decades, the pharmacological potential of BC for
he prevention and treatment of many types of cancer has received
rowing attention. The action mechanisms are still not fully under-
tood, but this carotenoid is believed to induce an apoptotic effect
n oncogenic cells, such as in colon cancer cells, leukemia cells
nd breast cancer cells [4–6]. However, previous studies, as, for
xample, the “˛-tocopherol, ˇ-carotene Cancer Prevention Study”
∗ Corresponding author.
E-mail address: clecio.ramos@ufrpe.com (C.S. Ramos).
ttp://dx.doi.org/10.1016/j.toxrep.2016.06.001
214-7500/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(ATBC) and the “ˇ-carotene and Retinol Efﬁcacy Trial” (CARET) both
showed that smokers and nonsmokers alike, with an intake of 40
and 30 mg/day of BC, respectively, increased the risk of cancer in
heavy smokers. Since then, various hypotheses have been proposed
to explain the negative results associated with tobacco smoking
[7–10]. The BC degradation products from cigarette smoke, such as
reactive aldehydes and epoxides are thought to help raise the risk
of cancer in smokers who  have a carotene-rich diet.
Tobacco smoking has declined in recent years in many coun-
tries due to the clear evidence of adverse health effects. The use
of Cannabis sativa,  for therapeutic or recreational purposes, how-
ever, has been growing in the world. This constitutes a public health
problem due to the harmful effects of the various toxic chemi-
cal substances released by the burning of the leaves and ﬂowers,
known to be the source of a variety of diseases such as lung cancer
[11].C. sativa is a bush in the Cannabaceae family. Its parts contain
varying levels of more than 480 substances, distributed in 18 chem-
ical classes, of which more than 60 are cannabinoids. This plant has
important therapeutic potential as well as psychotropic properties
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12,13]. Its pharmacological activity is associated with cannabi-
oid compounds, which are not found in other plant species.
annabinoid -9-tetrahidrocanabinol (THC) is its main psychoac-
ive component.
The medicinal use of this plant is legal in many American states
nd in countries such as Holland, Belgium and Canada, to allevi-
te symptoms of diseases such as cancer, AIDS, multiple sclerosis,
laucoma and Tourette’s syndrome. In Brazil, its use is still illegal.
he therapeutic application of C. sativa is still controversial due to
ts effects, generally associated with its intoxicating properties and
hronic systemic effects on people who are heavy users, besides the
ossible side effects [14,15].
Another problem of the regular smoking of C. sativa is the high
HC level in the bloodstream, which can induce anxiety attacks,
chizophrenia and precocious psychotic alterations in people who
re genetically predisposed [16]. One study showed that the use of
. sativa is associated with higher susceptibility to infections and
ncreased rates of head and neck cancer [17]. Those authors also
eported that THC has immunomodulatory properties, by reduc-
ng the ability of macrophages to produce cytokines, limiting their
apacity to recognize antigens, in turn weakening the cytolytic and
roliferative response of the T lymphocytes and the production of
ntibodies by the B lymphocytes.
Since there are no studies of the effect of BC associated with C.
ativa smoke (CSS), the aim of the present study was to compare
he possible alterations in the chemical and biological properties of
C after contact with C. sativa smoke.
. Materials and methods
.1. Materials
The ˇ-carotene (95% purity) was acquired from Sigma-Aldrich.
he C. Sativa was supplied by the Judicial Ofﬁce of the city of
imoeiro, state of Pernambuco, Brazil, after authorization by Judge
osé Claudionor da Silva Filho and by the Forensic Institute of Per-
ambuco, on the decision of its manager Dr. Luiz Carlos Soares da
ilva. The experiment of degradation of BC by CSS was  carried out
n the Police Science Laboratory of Pernambuco.
.2. Animals
Swiss mice (25–30 g) and Wistar rats (250–260 g) obtained from
he laboratory animal facilities of the Federal University of Per-
ambuco were used. The animals were housed in group cages
ith free access to food and water. The animals were treated
ccording to the ethical principles of the National Council for
xperimental Animal Control (CONCEA). The university’s animal
tudy committee approved the experimental protocols with num-
er 23076.012173/2007-77.
.3. Kinetic analysis of degradation of BC by CSS
The method used was that proposed by Lowe with modiﬁcations
10]. C. sativa smoke was  generated artiﬁcially using a ﬂexible sil-
cone hose measuring 10 cm in length. A cannabis cigarette was
nserted at one end, and the other end was attached to a 50-mL
isposable syringe. The cigarette was lit and the smoke was col-
ected in the syringe by suction. The syringe, ﬁlled with smoke, was
hen connected to another hose, whose other end was attached
o a glass Pasteur pipette. This injected the smoke into a BC solu-
ion in hexane, contained in a round-bottom ﬂask. The ﬂask was
hen closed and the solution was gently shaken. This process was
epeated each 20 min  for 2 h. With each smoke injection, an aliquot
f 0.2 mL  of the solution was removed and diluted in 2.8 mL  of
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for analysis with an Agilent 8453 UV–vis spectrophotometer, in
intervals from 300 to 600 nm,  using 10-mm quartz cuvettes. The
samples were analyzed at a concentration of 0.67 mg/mL in hex-
ane/dichloromethane/methanol. Two other curves were plotted:
a control kinetic curve, which was  obtained through the natural
degradation of a solution of BC in hexane at room temperature
(25.0 ◦C); and a calibration curve with the standard BC. All the
analyses were conducted in triplicate.
2.4. Degradation of BC by CSS
To degrade the BC, we  used the same method described above.
A solution of 7 M BC in hexane was  injected into CSS and this
was repeated every 20 min  for a period of 9 h, after which the hex-
ane was  removed with a rotary evaporator (40 ◦C) to obtain the
sample BC degraded by the C. sativa smoke (BCCSS). The entire
experiment was conducted at room temperature. Each cigarette
consumed generated about 400 mL  of smoke.
2.5. Analysis and identiﬁcation of the degraded ˇ-carotene
GC–MS
The BCCSS was  analyzed by gas chromatography-mass spec-
trometry (GC–MS), with an Agilent spectrometer equipped with
a silica capillary column (30 m × 0.25 mm × 0.25 m),  operating
under the following conditions: column ﬂow of 2.5 mL/min, using
helium as the carrier gas (1.5 mL/min); and column temperature
program from 60 ◦C to 320 ◦C at 3 ◦C min−1. The injector and detec-
tor temperatures were both 280 ◦C.
2.6. Antioxidant activity—ABTS•+ method
[2,2′-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)]
The antioxidant activity was  determined by the ABTS•+ free
radical sequestration method, as described previously [18]. The
sample of BCCSS was  obtained as described in paragraph 2.4 and
was diluted in ethanol.
2.7. Hemolytic assay
The hemolytic assay was  performed in a 96-well plate following
the method previously described [19]. Each well received 100 L
of a 0.85% NaCl solution containing 10 mM of CaCl2. The ﬁrst well
served as the negative control and contained the vehicle only (10%
DMSO). The second well contained 100 L of the test substance,
which was diluted 1:2. The other extracts were tested in con-
centrations ranging from 15.62 to 2000 g/mL. The serial dilution
continued until the 11th well. The last well received 20 L of 0.1%
Triton X-100 (in 0.85% saline) to obtain 100% hemolysis (positive
control). Each well received 100 L of a 2% suspension of mouse
erythrocytes in 0.85% saline containing 10 mM of CaCl2. After incu-
bation at room temperature for 30 min and centrifugation, the
supernatant was  removed, and the released hemoglobin was  mea-
sured by spectroscopic absorbance at 450 nm.  Extracts with an EC50
value lower than 200 g/mL were considered active, as previously
described [20].
2.8. Assessment of the toxicity of repeated doses in rats
The testing parameters were those determined by the Brazil
National Sanitary Surveillance Agency (ANVISA) and previously
reported [21]. Forty animals were allocated to four experimen-
tal groups of ten rats each (ﬁve males and ﬁve females). Each
animal received the following daily doses, by orogastric gavage:
control group received only the vehicle (corn oil); group BC received
2.5 mg/kg of BC solution; group CSS received 2.5 mg/kg of CSS
518 D.S. do Monte et al. / Toxicology Reports 3 (2016) 516–522
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vFig. 1. UV–vis spectra of -caro
olution; and group BCCSS received 2.5 mg/kg of BCCSS. The con-
umption of food and water and body weight were monitored daily,
long with the animals’ physical condition (assessment of urina-
ion, defecation, pelage, mucosa and posture) to detect possible
oxic effects. After administration of each dose, the behavior of the
entral and peripheral nervous systems was analyzed according
o the method previously proposed [21], every 30 min  for 4 h on
he ﬁrst day of the experiment and every hour for 4 h on the other
ays. The behavioral effects were classiﬁed as no effect, small effect,
edium effect or strong effect. On the 31st day, the animals were
nesthetized with 0.1–0.2 mL/100 g of a combination of ketamine
nd xylazine (2:1) and blood samples were collected by cardiac
uncture to perform the hematological and biochemical tests.
he hematological and biological indices were determined using
 Horiba ABX Micros 60 automatic analyzer and semi-automatic
iochemical analyzer, respectively. The animals were then euth-
nized and the organs (heart, lungs, stomach, kidneys, liver and
pleen) were removed for observation of macroscopic and micro-
copic changes.
.9. Assessment of toxicity against Artemia salina
To assess toxicity, we  used the method previously reported
22] with some modiﬁcations. The culture of this crustacean was
arried out in a plastic aquarium with 20 mg  of A. salina cysts
ncubated in artiﬁcial brine (37.5 g of sea salt per liter of distilled
ater) under continuous aeration, to maintain an oxygen-saturated
tate, with constant artiﬁcial illumination (40-W light bulb) for 24 h
or hatching. The test was run in triplicate with different sample
oncentrations (1000, 700, 500, 210, 100 and 50 g/mL), with a
nal volume of 5 mL  in each test tube. The negative control was a
olution containing A. salina without the sample solutions. BCCSS
amples were used, obtained as described in paragraph 2.4. Ten
arvae were transferred to each tube and maintained under artiﬁ-
ial lighting for 24 h. After this period, the living and dead larvae
ere counted. In bioactivity evaluation by brine shrimp bioassay,
ytotoxic activity is considered weak when the LC50 is between
00 and 1000 g/mL, moderate when the LC50 is between 100 and
00 g/mL, and strong when the LC50 is between 0 and 100 g/mL.
.10. Statistical analysisResults were expressed as the mean standard deviation of the
ean. The biomechanical data were compared with analysis of
ariance (ANOVA) using a two-way ANOVA and Tukey’s test (para-Fig. 2. Graphical plot of effective concentration values (EC50) of ABTS radical scav-
enging activities of the samples of BC, BCCSS and CSS.
metrictest). The data of assessment of toxicity using A. salina were
analyzed by quadratic polynomial regression using the BioEstat
program (version 5.3). To test of antiradical efﬁciency, the Graph-
Pad Prism 5.0 program (DEMO) was used at a conﬁdence interval
of 95% (p < 0.05), to obtain the EC50.
3. Results and discussion
3.1. Degradation of ˇ-carotene by C. sativa smoke
The degradation of BC in hexane by CSS for a period of 120 min
was monitored by UV–vis spectrometry. The spectrum of the BC
after 20 min  clearly showed a reduction of absorbance at 458 and
485 nm when compared with the BC without exposure to CSS, indi-
cating that the BC had undergone degradation (Fig. 1).
After two hours exposure to CSS, the BC was  degraded by
22.0%, a mean degradation rate of 0.18% per minute. The degra-
dation of the BC without the presence of CSS (hexane only) at
room temperature (25 ◦C) was  2.0%, that is at an average rate of
0.017% per minute. There was  also loss of color in the solution
containing BC and hexane, which changed from reddish-orange
to orange, indicating a change in the chemical structure of the
BC. Based on the degradation kinetic curve, the theoretical cal-
culation indicated that the BC would be completely degraded
after 9 h into the experiment (27 smoke injections). In reality,
this degradation after 9 h was  98.8%. The corresponding degrada-
tion after 9 h of the BC in hexane with injections of air without
CSS was  8.4%. The chemical proﬁle obtained by GC–MS of the
BC samples after contact with the CSS identiﬁed the presence
of 13 compounds, representing 81.7% of the sample’s chem-
ical composition. Of these 13 compounds, 6 were related to
D.S. do Monte et al. / Toxicology Reports 3 (2016) 516–522 519
Table  1
Identiﬁed compounds by GC–MS after -carotene exposed to C. sativa smoke.
N◦ Compound Molecular formula RT min % Main fragments (m/z)
1 (3-Hydroxy−2,4,4-trimethylpentyl)2-methylpropanoatea C12H24O3 19.5 30.0 43, 56, 71, 83, 98
2  (2-ethyl−3-hydroxyhexyl)2-methylpropanoatea C12H24O3 20.5 20.1 43, 56, 71, 89, 173
3  dihydroactinidiolidea C11H16O2 26.2 3.0 43, 111, 137, 180
ˇ-cyclocitrala C10H16O 32.6 3.7 69, 109, 137, 152
4  Cannabidiol C21H30O2 47.9 0.3 55, 147, 231, 267
5  2-tridecen−1-ala C13H24O 49.2 1.0 43, 149, 167, 231
6  Ergost-5-en-3-ol, acetate, (3ˇ,24R) C30H50O2 49.5 0.4 43, 55, 231, 367
7  9-tetrahydrocannabinol C21H30O2 50.3 11.4 258, 271, 299, 314
8  Cannabigerol C21H32O2 51.2 1.0 43, 55, 69, 123, 193, 231, 295
9  Cannabinol C21H26O2 51.6 5.4 119, 238, 295, 310
10  Hexadecane,6, 11-dipentyl C26H54 53.3 1.1 43,71, 85, 295, 313
11  Farnesol isomer Aa C15H26O 53.7 3.2 55, 69, 81, 95, 295
12  Hexatriacontane C36H74 55.1 0.9 43, 57, 71, 85, 99
13  Tetracosane, 9-octyl- C32H66 56.3 0.2 43, 57, 71, 85
TOTAL  – – 81.7 –
a Probable degradation products of BC after exposure to CSS.
Table 2
Values of water and food consumption, variation in body and organ weight of male and female rats after exposure to BC, CSS and BCCSS for 30 days.
Groups Animals Water (ml) Food (g) Body (g) Lung (g) Heart (g) Liver (g) Kidney (g) Spleen (g) Stomach (g)
Negative
control
Male 181.1 ± 29.9 156.4 ± 14.9 320.4 ± 3.7 1.96 ± 0.23 1.23 ± 0.07 12.27 ± 0.95 2.49 ± 0.14 1.02 ± 0.15 1.72 ± 0.06
Female  153.5 ± 30.0 99.14 ± 14.0 246.9 ± 14.6 1.92 ± 0.05 1.03 ± 0.07 9.82 ± 0.60 2.38 ± 0.16 0.69 ± 0.07 1.75 ± 0.20
BC Male  158.8 ± 17.1 144.7 ± 13.4 309.7 ± 6.7 1.77 ± 0.25 1.12 ± 0.06 11.06 ± 0.55 2.20 ± 0.16 0.82 ± 0.08 1.68 ± 0.09
Female  176.9 ± 40.3 109.7 ± 24.2 258.2 ± 5.1 1.92 ± 0.13 1.00 ± 0.08 9.14 ± 0.79 2.34 ± 0.20 0.85 ± 0.06 1.77 ± 0.19
CSS Male  167.9 ± 30.0 141.7 ± 13.8 314.2 ± 18.4 1.83 ± 0.18 1.18 ± 0.15 11.82 ± 0.81 2.41 ± 0.23 0.94 ± 0.04 1.81 ± 0.15
Female  192.5 ± 33.5 122.1 ± 25.6 251.3 ± 10.8 1.82 ± 0.11 0.93 ± 0.12 9.43 ± 0.70 2.14 ± 0.13 0.73 ± 0.14 1.73 ± 0.10
BCCSS Male  162.9 ± 19.1 136.5 ± 18.5 318.9 ± 11.9 1.88 ± 0.35 1.11 ± 0.12 11.08 ± 0.56 2.37 ± 0.09 0.85 ± 0.07 1.76 ± 0.07
Female  197.3 ± 44.5 116.6 ± 20.4 238.9 ± 5.2 1.73 ± 0.24 0.91 ± 0.06 8.25 ± 0.42 2.12 ± 0.27 0.68 ± 0.12 1.70 ± 0.12
The data represent the mean ± standard deviation. p < 0.05.
Table 3
Assessment of the biochemical parameters of male and female rats after exposure to BC, CSS and BCCSS for 30 days.
Biochemical parameters Animals Negative control BC CSS BCCSS
Urea (mg/dL) Male 33.45 ± 3.96 38.14 ± 4.28 38.49 ± 3.24 26.70 ± 3.56
Female  42.80 ± 8.70 38.92 ± 9.00 22.06 ± 2.2 26.10 ± 5.20
Creatinine (mg/dL) Male 0.20 ± 0.07 0.28 ± 0.10 0.20 ± 0.08 0.31 ± 0.09
Female  0.38 ± 0.10 0.32 ± 0.13 0.22 ± 0.04 0.22 ± 0.10
AST  (U/L) Male 79.38 ± 34.71 120.3 ± 21.82 85.80 ± 20.13 76.57 ± 20.13
Female  67.67 ± 18.5 90.22 ± 28.9 64.55 ± 23.4 62.42 ± 28.60
ALT  (U/L) Male 25.57 ± 5.70 36.41 ± 4.70 31.26 ± 6.9 29.39 ± 5.30
Female  40.14 ± 5.24 47.78 ± 14.70 27.93 ± 7.64 37.92 ± 8.16
Bilirubin (mg/dL) Male 0.05 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 0.07 ± 0.01
Female  0.19 ± 0.05 0.15 ± 0.02 0.10 ± 0.03* 0.08 ± 0.03*
AF  (mU/mL) Male 132.4 ± 10.21 234.0 ± 67.87 160.6 ± 26.78 207.6 ± 85.80
T  amin
d
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CFemale  316.6 ± 19.02 
he data represent the mean ± standard deviation. p < 0.05; *p < 0.01.AST—aspartate
egradation products of the BC after exposure to CSS (Table 1).
he major compounds identiﬁed ﬁrstly as BC degradation prod-
cts were 3-hydroxy-2,4,4-trimethylpentyl)2-methylpropanoate
nd (2-ethyl-3-hydroxyhexyl)2-methylpropanoate. In a previous
tudy, the 3-hydroxy-2,4,4-trimethylpentyl)2-methylpropanoate
nd similar compounds were found at higher levels in the exha-
ations of colorectal cancer patients [23]. The presence these
olatile organic compounds in exhalations from cancer patients is
ssociated with excessive oxidation reactions and high levels of
ytochrome P450 activity by lipid peroxidation of polyunsaturated
atty acids [24]. One of the major cytotoxic compounds identiﬁed
s lipid peroxidation product is the 4-hydroxy-2-nonenal, which is
oxic for the liver and the kidneys. The lipid peroxidation causes
erious membrane damage and may  therefore lead to cell death.
ompound antioxidants such as BC and -tocopherol may  avoid244.9 ± 61.75 109.0 ± 14.8* 211.8 ± 59.50*
otransferase; ALT—alanine aminotransferase; AF—alkaline phosphatase.
peroxidation. Our study, for the ﬁrst time, clearly showed that BC
is degraded by CSS, generating compounds identical to degraded
products of lipid content in humans, owing to oxidative stress.
Previous studies of BC oxidative cleavage in vitro revealed that
the major degradation products identiﬁed were ˇ-cyclocitral, ˇ-
ionone, ionene, and these ˇ-carotene metabolites products may  be
associated to the carcinogenic response in the lungs of cigarette
smokers [25]. The compound ˇ-cyclocitral product of oxidative
cleavage reaction of ˇ-carotene was also identiﬁed here. BC degra-
dation products induce genotoxic effects at concentrations which
may  occur under conditions of intense oxidative stress, e.g. induced
by a smoker who smokes an excessive number of cigarettes [26].
Considering the high degree of degradation of BC by CSS and
the known antioxidant activity of BC, possible loss of BC antiox-
idant potential was investigated. The samples of BC, BCCSS and
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Table 4
Differential count and evaluation of leukocytes of the male and female rats submitted to 30 days of exposure to BC, CSS and BCCSS.
Animals Negative Control BC CSS BCCSS
Leukocytes (103/mm3) Male 3.60 ± 0.9 5.86 ± 2.1 8.75 ± 1.1* 6.76 ± 1.3*
Female 5.08 ± 0.6 5.20 ± 1.2 3.32 ± 0.6* 3.37 ± 0.7*
Targeted (%) Male 21.46 ± 8.3 28.1 ± 3.7 24.00 ± 4.2 22.58 ± 5.6
Female 23.25 ± 2.1 20.61 ± 4.8 19.25 ± 4.1 17.62 ± 3.9
Rods  (%) Male 1.30 ± 0.7 1.60 ± 0.8 1.20 ± 0.3 2.25 ± 1.3
Female 0.58 ± 0.5 0.53 ± 0.5 0.75 ± 0.4 0.75 ± 0.4
Eosinophils (%) Male 0.69 ± 0.6 0.70 ± 0.5 1.10 ± 0.2 0.66 ± 0.7
Female 0.50 ± 0.5 0.38 ± 0.4 0.75 ± 0.7 –
Lymphocytes (%) Male 68.92 ± 8.2 65.7 ± 4.0 71.20 ± 4.5 79.75 ± 4.7*
Female 70.08 ± 4.1 75.92 ± 5.2 76.83 ± 5.5 –
Monocytes (%) Male 3.76 ± 1.6 3.90 ± 1.1 2.70 ± 1.4 3.33 ± 1.8
Female 5.58 ± 3.7 2.53 ± 1.3 2.41 ± 1.4 1.87 ± 0,9
Basophils (%) Male – – – –
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he data represent the mean ± standard deviation. p < 0.05; *p < 0.01.
SS presented sequestration activity of the radical cation ABTS·+,
ith EC50 values varying from 6.67 to 19.70 g mL−1 (Fig. 2). BC
6.67 ± 0.27 g mL−1) was the substance with the best antiradical
ctivity in relation to the standard, Trolox (2.60 ± 0.27 g mL−1).
his result was expected, because the antioxidant property of BC
as been widely studied and is well known. Indeed, BC is used as
 standard substance in some antioxidant tests. The EC50 result for
he BCCSS (18.53 ± 1.1 g mL−1) indicated that the electron seques-
ration capacity of the BC was reduced by about three times after
ontact with the CSS. The signiﬁcant decrease in antioxidant activ-
ty of the BC, after contact with the CSS, was due to the BC’s chemical
tructure having undergone chemical changes with a loss of its
hemical conjugation and generating non-conjugated degradation
roducts. These compounds with highly conjugated structures, as
n case of BC, had high antioxidant potential. The EC50 values of
he BCCSS versus CSS (19.70 ± 0.48 g mL−1) presented a small but
igniﬁcant difference between the results, which can conﬁrm the
eduction of the antioxidant property of the BC in this sample. This
ifference is probably related to the small quantity of BC still exist-
ng in the composition of the BCCSS sample.
.2. Assessment of toxicity in the microcrustacean Artemia salina
The purpose of the bioassay with Artemia salina was  to obtain
nformation on the toxicity of the samples, including to subse-
uent toxicological studies. The BC did not cause mortality of
. salina in all the tested concentrations (LC50 > 1000 mg/mL),
hus being considered non-toxic. The sample BCCSS presented
 LC50 = 397.35 mg/mL, while the sample of CCS presented a
C50 = 461.86 mg/mL. Both samples considered were toxic against
. salina,  demonstrating that the BC the compound proved to be
oxic after contact with CSS. This is because the CCS degrades the
C, generating oxidative degradation products, such as unsaturated
cids, aldehydes, ketones and alcohols, compounds identical to the
ipid peroxidation products and generally toxic.
.3. Assessment of the hemolytic potential in mouse erythrocytes
The samples were tested up to a concentration of 500 g/mL
nd none of them caused signiﬁcant alterations in the erythrocytes’
lasma membranes.The percentages of hemolyzed cells (%HC) at a concentration
f 500 g/mL were evaluated. None of the samples reached the
ercentage considered harmful, of 50% (BC = 0.69%; CSS = 5.08%;
CCSS = 16.73%). These results also indicate that the EC50 is above– – –
500 g/mL. Although the results showed that the samples did not
have activity, one comparison deserves mention: the BCCSS had a
higher hemolytic percentage than the CSS alone.
3.4. Assessment of the toxicity of repeated doses in rats
We  evaluated the behavior of the groups after administration of
the daily doses. On the ﬁrst day, the animals (males and females)
that received the CSS and BCCSS presented a reduction in corneal
reﬂex, palpebral ptosis and ambulation, remaining in this state dur-
ing the ﬁrst hour. These effects were observed during the ﬁrst seven
days of the experiment after each administration, and might be
related to the THC present in the CSS and BCCSS, since this cannabi-
noid is known for its sedative and somnolence effects. These effects
were only observed in the ﬁrst seven days, probably because of
the development of tolerance to the drug [27], which is a serious
problem found in patients treated with cannabinoids. The group of
females submitted to BCCSS showed intense irritability and mod-
erate vocalization in the ﬁrst 20 days of the experiment, before and
after administration.
There were no signiﬁcant differences in water and food con-
sumption and body weight in the treated groups in comparison
with the negative control group, demonstrating that the samples
probably did not cause any alterations in the animals’ metabolism.
With respect to the organ weights of the male rats, no signiﬁcant
alteration was  observed in the weights of the heart, liver, kidneys,
spleen and stomach (Table 2). However, in the females, there was a
difference in the liver weight for the BCCSS group. Also, the anatom-
pathological analysis of these organs revealed small whitish spots
in the liver of two  females treated with BCCSS. These are generally
associated with ﬁbrosis, but no changes were observed in the mor-
phology, size or color of these organs. In previous study with rat,
whitish markings were found around the terminal hepatic veins on
the liver surface after administration of carbon tetrachloride due to
white blood cell inﬁltration [28]. Here, it was not possible to asso-
ciate the whitish sports found in the liver with a particular type of
disease.
BC is carried in the bloodstream by lipoproteins and it is stored
mainly in the adipose tissue and liver. Its conversion into retinoids
occurs in various organs, such as the liver, lungs and kidneys
[29]. Therefore, biochemical analyses of the animals’ blood were
chosen referentially to obtain parameters to indicate changes in
the organs such as the liver and kidneys. No signiﬁcant changes
were observed in the biochemical parameters analyzed in the male
animals (Table 3). However, reductions in the concentration of
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Table  5
Assessment of the red blood cells of male and female rats after exposure to BC, CSS and BCCSS for 30 days.
Animals Negative Control BC CSS BCCSS
RCB (106/mm3) Male 4.22 ± 1.0 4.343 ± 0.8 4.742 ± 0.4 4.19 ± 1.2
Female 7.58 ± 0.2 7.32 ± 0.3 7.70 ± 0.3 7.77 ± 0.4
Hemoglobin (g/dL) Male 7.68 ± 1.7 8.050 ± 1.5 8.860 ± 0.8 8.58 ± 0.8
Female 14.27 ± 0.3 13.93 ± 0.5 14.70 ± 0.7 14.16 ± 0.8
Hematocrit (%) Male 21.63 ± 5.4 22.78 ± 4.4 24.46 ± 2.3 23.86 ± 2.5
Female 42.45 ± 1.3 41.50 ± 1.5 43.16 ± 2.1 42.00 ± 2.2
MCV  (m3) Male 51.14 ± 1.5 52.33 ± 1.9 51.40 ± 0.9 51.00 ± 1.5
Female 56.00 ± 1.5 56.67 ± 2.0 56.14 ± 1.3 53.90 ± 1.1
MCH  (g.10−12) Male 18.21 ± 0.9 18.52 ± 0.4 18.64 ± 0.2 18.52 ± 0.2
Female 18.72 ± 0.4 19.00 ± 0.7 19.10 ± 0.6 18.20 ± 0.4
MCHC  (g/dL) Male 35.70 ± 1.6 35.42 ± 0.7 36.16 ± 0.2 36.25 ± 0.9
Female 33.67 ± 0.8 33.58 ± 0.1 34.06 ± 0.8 33.72 ± 0.6
RDW  (%) Male 13.59 ± 0.6 14.37 ± 1.2 13.34 ± 0.3 13.57 ± 0.7
Female 14.78 ± 0.4 14.23 ± 0.8 14.60 ± 0.5 14.02 ± 0.7
The data represent the mean ± standard deviation p < 0.05. RBC—red blood cells; MCV—
corpuscular hemoglobin concentration; RDW—red cell distribution width.
Fig. 3. Cortical region of the kidneys of male Wistar rats submitted to 30 days of
exposure A—kidney of the control group; B—kidney of the BCCSS group (male rat);
C
m
b
t
g
i
e—kidney of the BCCSS group (female rat). *yellow arrow—amorphous eosinophilic
aterial.
ilirubin and the enzyme alkaline phosphatase were observed in
he females that received CSS and BCSS in relation to the control
roup.In adults, carotene supplements such as BC stimulates the
mmune response by averting low white blood cell counts. How-
ver, our data showed that in the analysis of the white blood cells, mean corpuscular volume; MCH—mean corpuscular hemoglobin; MCHC—mean
the groups treated with CSS and BCCSS presented a reduction in
the number of leukocytes in the in the females, compared to the
control group (Table 4).
In the assessment of the hematological parameters, no signiﬁ-
cant differences were observed in the red blood cells, hemoglobin
concentration and hematocrit count, and no erythrocyte anomalies
were detected (Table 5).
In the histopathological analysis of the organs, only the kidneys
of the male and female rats treated with BCCSS presented alter-
ations. In the kidneys of these animals, the cortical region contained
amorphous eosinophilic material (cylinders) in the lumen of the
proximal and distal convoluted tubules (Fig. 3). Discrete lympho-
plasmacytic interstitial nephritis was  also observed in the groups
treated with CSS and BCCSS.
The presence of cylinders can be related to various factors, such
as problems of protein reabsorption, nephritis and renal tubular
lesion. This can indicate toxicity, since the formation of intratubular
cylinders can obstruct the tubules and impair their function [30].
However, other examinations need to be conducted to establish the
origin of these cylinders.
4. Conclusion
The BC is an important natural carotenoid for human health
by acting to prevent various diseases including lung cancer and
as it is a precursor of vitamin A. Its chemical structure with forty
carbon atoms and the fact that it is highly conjugated makes it sen-
sitive to a degradation that can generate various potentially toxic
compounds. In this study we  show that the CSS exposed to BCC
undergoes changes in its chemical structure, altering its biological
properties and losing its antioxidant potential by about three times.
In rats, although females were more sensitive, in both sexes, after
repeated doses of BCCSS, the kidneys showed discrete amorphous
eosinophilic material (cylinders) in the lumen of the proximate
and distal convoluted tubules, besides discrete lymphoplasmacytic
interstitial nephritis. Thus, this study shows that BC intake together
with CSS should not be encouraged due to toxicity and loss of
antioxidant activity of the BC after contact with the CSS.Conﬂict of interest
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